Tango Therapeutics (TNGX) Hits All-Time High as Analyst Turns Bullish [Yahoo! Finance]
Tango Therapeutics (TNGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Tango Therapeutics GAAP EPS of -$0.29 beats by $0.03, revenue of $0M misses by $0.5M [Seeking Alpha]
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing [Yahoo! Finance]